Childhood-Onset Fluency Disorder
2 clinical trials · Condition
◉ Watch Childhood-Onset Fluency Disorder
| Record | Firm | Date |
|---|---|---|
| A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) (NCT05583955) | Noema Pharma AG | 2022-07-25 |
| Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). (NCT02909088) | Gerald Maguire, MD | 2016-09-01 |
Track Childhood-Onset Fluency Disorder automatically
Every clearance here is in the API, with alerts when new ones post.